Literature DB >> 10833493

Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats.

J M Barrios1, L M Lichtenberger.   

Abstract

BACKGROUND & AIMS: We explored the role of biliary phosphatidylcholine (PC) in protection of the intestinal mucosa against bile salt (BS)-induced intestinal injury and how this property may be blocked by indomethacin (Indo), a nonsteroidal anti-inflammatory drug (NSAID) that is secreted into the bile.
METHODS: We performed in vivo studies in which bile was collected over a 2-hour period after rats were intragastrically administered Indo (25 mg/kg) or an equivalent volume of saline (controls). The bile samples (some of which were supplemented with PC) were then instilled into a loop of distal ileum of anesthetized rats. After a 30-minute exposure period, we measured the hemoglobin concentration of the ileal loop fluid, as an index of bleeding, and mucosal contact angles, as an index of surface hydrophobicity. A similar in vivo experiment was performed in which model bile containing 5 mmol/L each of the BS, sodium deoxycholate, PC, or Indo, alone and in combination, was instilled into ileal loops. In our in vitro test system, human erythrocytes were exposed to the above biliary constituents, and hemolysis was measured spectrophotometrically.
RESULTS: Bile from Indo-pretreated rats decreased the surface hydrophobicity and induced bleeding of ileal loops in comparison with control bile, and both NSAID-induced changes were reversed if PC was added to the bile. Similarly, synthetic BS caused gastrointestinal bleeding, decreased ileal contact angles, and induced erythrocyte hemolysis, all of which were reversed by addition of equimolar PC. This protective role of PC in both the in vivo and in vitro systems was partially blocked by Indo, although the NSAID had no effect on these properties on its own.
CONCLUSIONS: These findings support the hypothesis that PC protects the intestinal mucosa against injurious actions of BS, possibly by forming less toxic mixed micelles. Indo and perhaps other NSAIDs that enter the bile may damage the mucosa, not by a direct action, but by competing for the available protective PC molecules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833493     DOI: 10.1016/s0016-5085(00)70371-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  27 in total

1.  Wireless capsule endoscopy in enteropathy induced by nonsteroidal anti-inflammatory drugs in pigs.

Authors:  Ilja Tachecí; Jaroslav Kvetina; Jan Bures; Jan Osterreicher; Martin Kunes; Jaroslav Pejchal; Stanislav Rejchrt; Stanislav Spelda; Marcela Kopácová
Journal:  Dig Dis Sci       Date:  2009-12-16       Impact factor: 3.199

Review 2.  Bile acid interactions with cholangiocytes.

Authors:  Xuefeng Xia; Heather Francis; Shannon Glaser; Gianfranco Alpini; Gene LeSage
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.

Authors:  Mohamed S Hashim Abdalla; Simon D Taylor-Robinson; Amar W Sharif; Horace R T Williams; Mary M E Crossey; Gamal A Badra; Andrew V Thillainayagam; Devinder S Bansi; Howard C Thomas; Imam A Waked; Shahid A Khan
Journal:  HPB (Oxford)       Date:  2011-03-22       Impact factor: 3.647

4.  Aggregation behavior of ibuprofen, cholic acid and dodecylphosphocholine micelles.

Authors:  Priyanka Prakash; Abdallah Sayyed-Ahmad; Yong Zhou; David E Volk; David G Gorenstein; Elizabeth Dial; Lenard M Lichtenberger; Alemayehu A Gorfe
Journal:  Biochim Biophys Acta       Date:  2012-08-04

5.  Systemic phosphatidylcholine pretreatment protects canine esophageal mucosa during acute experimental biliary reflux.

Authors:  Gabor Eros; Jozsef Kaszaki; Miklos Czobel; Mihaly Boros
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

6.  Lipodissolve for body sculpting: safety, effectiveness, and patient satisfaction.

Authors:  Khalid Mahmud; Charles E Crutchfield
Journal:  J Clin Aesthet Dermatol       Date:  2012-10

7.  Gastrointestinal safety and therapeutic efficacy of parenterally administered phosphatidylcholine-associated indomethacin in rodent model systems.

Authors:  L M Lichtenberger; J J Romero; E J Dial
Journal:  Br J Pharmacol       Date:  2009-04-20       Impact factor: 8.739

8.  The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora.

Authors:  Satoshi Kamiya; Masato Nagino; Hidetoshi Kanazawa; Shunichiro Komatsu; Toshihiko Mayumi; Kenji Takagi; Takashi Asahara; Koji Nomoto; Ryuichiro Tanaka; Yuji Nimura
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

9.  Anti-inflammatory effects of phosphatidylcholine.

Authors:  Irina Treede; Annika Braun; Richard Sparla; Mark Kühnel; Thomas Giese; Jerrold R Turner; Elsa Anes; Hasan Kulaksiz; Joachim Füllekrug; Wolfgang Stremmel; Gareth Griffiths; Robert Ehehalt
Journal:  J Biol Chem       Date:  2007-07-18       Impact factor: 5.157

10.  Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis.

Authors:  Gabor Eros; Saleh Ibrahim; Nikolai Siebert; Mihály Boros; Brigitte Vollmar
Journal:  Arthritis Res Ther       Date:  2009-03-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.